CHARLESTON, W.Va. (Legal Newsline) -- The trials against three major transvaginal mesh manufacturers will begin next December, according to a judicial report.
A report detailing the decisions from a Dec. 6 status conference show that the trials will begin Dec. 3, 2013, in the U.S. District Court for the Southern District of West Virginia.
The first scheduled trial is a consolidated case in "In re: American Medical Systems, Inc., Pelvic Repair System Products Liability Litigation (MDL No. 2325)." After that, the trials of cases in "In re: Ethicon, Inc., Pelvic Repair Systems Products Liability Litigation (MDL No. 2327)" and "In re: Boston Scientific Corp., Pelvic Repair Systems Products Liability Litigation (MDL No. 2326)" are set."
Trial of a case consolidated in "In re: C.R. Bard, Inc., Pelvic Repair Systems Products Liability Litigation (MDL No. 2187)" will begin in February, according to the status conference report. U.S. District Judge Joseph R. Goodwin is overseeing all six federal transvaginal mesh multidistrict litigation matters.
"The scheduling of these trials means those who believe they have been injured by their transvaginal mesh surgeries are one step closer to the possibility of being made whole again," Rochelle Rottenstein, principal of the Rottenstein Law Group which represents transvaginal mesh patients nationally, said in a press release.
Since 2011, the U.S. Food and Drug Administration has received reports of problems associated with transvaginal mesh used to treat pelvic organ prolapse stress urinary incontinence. Some side effects include bleeding, urinary problems, pain and infection.